Short answer: Canada approves no cosmetic before sale; the system runs on notification — a Cosmetic Notification Form filed within 10 days of first sale — backed by an ingredient Hotlist and bilingual labelling. The notification form has been rebuilt since 2024, fragrance allergen disclosure is phasing in through 2026, and a Hotlist amendment is being finalised with no transition period attached.
Among the large English-speaking destinations, Canada is the one brands prepare for least, usually because it looks like a light version of the United States. It is not. The machinery is different in kind: no pre-market registration, a locally accountable party, an administrative ingredient list that can change without a gazetted phase-in, and two mandatory languages on every panel.
This guide sets out the notification duty, the modernisation timeline of the form behind it, the allergen change with the widest reach, the Hotlist update that is being finalised now, and the mistakes that show up in import-side reviews.
No approval — notification within 10 days of first sale
Canada's route is notification-based. A cosmetic must be notified to Health Canada within 10 days after it is first sold in Canada, through the Cosmetic Notification Form. The form carries the product identity, the party responsible in Canada, the full formula with concentration ranges, and the function of the product.
Three properties of this system surprise newcomers. First, the notification is not an approval — a submission being on file does not certify the product's compliance or even its classification as a cosmetic. Second, the duty is continuous: changes to the formula, the brand name or contact details require an amendment within 10 days, and ceasing sale requires a discontinuation notice. Third, the obligation has teeth — a product that has not been properly notified after the 10-day window cannot legally be sold.
The practical reading for an importer: the notification is a living record, not a one-time filing. A documentation chain that updates when the formula changes is the difference between a maintained record and a liability.
The notification form has been rebuilt since 2024
Between late 2024 and spring 2026 the notification framework was revised in stages, and forms filed years ago increasingly lag what Health Canada expects. The dates below define the modern form.
| Date | Change in force |
|---|---|
| Late 2024 | Manufacturer definition rewritten; a person in Canada authorised to act for a foreign seller becomes the accountable party; inner label must carry digital contact information |
| 5 March 2025 | Canadian address required on the form for the manufacturer or importer |
| 2025–2026 | Concentration range codes expanded from 7 to 13, giving finer formulation detail |
| 12 April 2026 | First-stage fragrance allergen disclosure: allergens above threshold declared individually, outside the word "parfum" |
| 1 August 2026 | Expanded allergen list (around 80 allergens) applies to products newly placed on the market |
| 1 August 2028 | Transition deadline for existing products under the expanded allergen labelling |
The rewritten manufacturer definition matters most for foreign brands: where no Canadian responsible person has been designated, the importer is treated as the manufacturer for notification purposes. Either way, a Canadian address on the form is mandatory — a head-office address abroad does not satisfy it.
Fragrance allergens: the change with the widest reach
The allergen rules have two halves that must be tracked separately. The labelling half requires allergens present above threshold — 0.001% in leave-on products, 0.01% in rinse-off — to be named individually in the ingredient list rather than hidden inside "parfum". Canada aligned its allergen list to the EU's expanded annex, which is convenient for brands that have already done EU allergen labelling work: the fragrance-house declarations obtained for Europe largely do double duty, provided the calculation is redone for the Canadian product as actually sold.
The notification half is easy to miss: the allergen disclosure also flows into the Cosmetic Notification Form, and the form's formula data must match the commercial label. A brand that updates its artwork for the expanded list but leaves the form's fragrance section untouched has created exactly the mismatch a review or complaint investigation surfaces first.
Threshold calculations use the concentration in the finished product, which means quantitative declarations from fragrance and complex-ingredient suppliers — not qualitative ones — are the working input. EU labelling fundamentals translate here better than US conventions do, because the Canadian ingredient-list format descends from the same tradition.
The Hotlist update: why preparation beats reaction
The Cosmetic Ingredient Hotlist is Health Canada's administrative list of substances prohibited or restricted in cosmetics. It is not a regulation in itself, but selling a product that breaches its conditions is treated as contravening the Food and Drugs Act — which makes the list operationally binding.
Health Canada ran a consultation on proposed Hotlist updates from 19 November 2025 to 17 February 2026; the final list is now being prepared. The proposals include restrictions on polyaminopropyl biguanide (PHMB) and two colourant substances, an expanded prohibition of comfrey, brucine moving from restricted to prohibited, and tightened furocoumarin controls — including a 1 ppm ceiling on naturally occurring amounts in leave-on products, which reaches botanical extracts that never declared a furocoumarin on purpose.
The structural point is the one to plan around: a Hotlist update generally applies when the revised list is published, and it does not come with the transition periods a gazetted regulation would carry. Preparation therefore has to happen before publication — a formula inventory screened against the proposed entries, substitution options identified for any hits, and notification amendments ready to file. The brands that wait for the published list will be reformulating against a live compliance gap, and their experience with that pattern in other markets says the documentation tail is the expensive part.
Bilingual labels and the contact-point rule
Every mandatory label statement must appear in both English and French: product identity, net quantity in metric units, the full INCI list in descending order of concentration, the Canadian manufacturer or importer name and address, the product's function, and any required warnings. Small packages are not exempt, which forces early decisions about panel space — a reason to lock label architecture before the artwork is commissioned, not after.
The 2024 amendments also require digital contact information (a QR code, web or email address) on the inner label, giving consumers a channel for questions and complaints. This is a small print item with a real function: it is the hook the complaint-driven surveillance model hangs on.
The mistakes import-side reviews keep finding
Treating the Canadian entry as a US add-on. The systems differ in kind — notification versus listing, bilingual artwork, a Hotlist with its own logic. Copying US labels with a French sticker is the classic failure.
The stale notification. Formulas evolve quietly; a form that describes the version of the product from two years ago is a mismatch waiting for an investigation. Amend within the 10-day window when things change.
Screening only intentional ingredients. Furocoumarins in citrus oils or pyrrolizidine alkaloids in botanical extracts enter with the raw material, not the brief. The proposed Hotlist entries target exactly these carry-over cases, so the screen has to run against supplier documentation, not just the formula sheet.
FAQ
Q: Does Canada require pre-market approval for cosmetics? A: No. Canada has no pre-market cosmetic approval. The product must be notified to Health Canada through the Cosmetic Notification Form within 10 days after first sale, the form must carry a Canadian address and the full formula, and the notification is not an approval — it is a record that the product must have before it can legally be sold.
Q: What fragrance allergens must be declared on Canadian cosmetic labels? A: Allergens present above 0.001% in leave-on products or 0.01% in rinse-off products must be individually declared in the ingredient list, outside the word "parfum". The disclosure applied to 24 allergens from 12 April 2026, expanded to the full list of around 80 for newly marketed products from 1 August 2026, with existing products transitioning by 1 August 2028.
Q: What is the Canadian Cosmetic Ingredient Hotlist? A: It is Health Canada's administrative list of substances prohibited or restricted in cosmetics sold in Canada. A product breaching its conditions is treated as contravening the Food and Drugs Act. The 2026 update — consulted from 19 November 2025 to 17 February 2026 — is being finalised, and a Hotlist update generally applies on publication without a transition period.
Q: Who is responsible for the Canadian cosmetic notification of an imported product? A: A person in Canada — either the seller under its own name or a party authorised to act for the foreign brand — is the accountable party, and the form requires a Canadian address. Where no responsible person has been designated, the importer is treated as the manufacturer for notification purposes.